Combined use of erythropoietin and G-CSF in the treatment of myelodysplastic syndromes
- PMID: 10586204
Combined use of erythropoietin and G-CSF in the treatment of myelodysplastic syndromes
Comment on
-
Erythropoietin plus granulocyte colony-stimulating factor in the treatment of myelodysplastic syndromes. Identification of a subgroup of responders. The Spanish Erythropathology Group.Haematologica. 1999 Dec;84(12):1058-64. Haematologica. 1999. PMID: 10586205 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical